Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Change in Cash (2016 - 2026)

Insight Molecular Diagnostics' Change in Cash history spans 6 years, with the latest figure at -$7.3 million for Q4 2025.

  • On a quarterly basis, Change in Cash fell 238.27% to -$7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 424.5% increase, with the full-year FY2025 number at $2.6 million, up 424.5% from a year prior.
  • Change in Cash hit -$7.3 million in Q4 2025 for Insight Molecular Diagnostics, down from -$5.8 million in the prior quarter.
  • Over the last five years, Change in Cash for IMDX hit a ceiling of $51.8 million in Q1 2021 and a floor of -$15.2 million in Q1 2022.
  • Historically, Change in Cash has averaged $203800.0 across 5 years, with a median of -$5.1 million in 2023.
  • The widest YoY moves for Change in Cash: up 1041.85% in 2021, down 5764.38% in 2021.
  • Tracing IMDX's Change in Cash over 5 years: stood at -$7.7 million in 2021, then crashed by 36.39% to -$10.5 million in 2022, then skyrocketed by 58.76% to -$4.4 million in 2023, then surged by 221.19% to $5.3 million in 2024, then tumbled by 238.27% to -$7.3 million in 2025.
  • Business Quant data shows Change in Cash for IMDX at -$7.3 million in Q4 2025, -$5.8 million in Q3 2025, and -$6.7 million in Q2 2025.